There are 2789 resources available
41P - Testosterone level and severity of COVID-19 infection in ambispective cohorts: The TESTOVID study
Presenter: Johanna Noel
Session: ePoster Display
42P - Analysis of canonical uveal melanoma aberrations in murine uveal melanocytes
Presenter: Yoseph Sayegh
Session: ePoster Display
43P - Exploring the immune contexture within tumor microenvironment in non-small cell lung carcinoma (NSCLC) by multiplex immunohistochemistry
Presenter: Chih-Hung Ye
Session: ePoster Display
44P - All-trans retinoic acid modulates H19, telomerase, miR-let-7a, and glycolytic metabolism in breast cancer
Presenter: Rita El Habre
Session: ePoster Display
45P - Analysis of HER2 distribution concordance in breast cancer tissue by serial IHC staining
Presenter: Guan-Ru Peng
Session: ePoster Display
Resources:
Abstract
46P - Intraperitoneal perfusion with sodium bicarbonate solution can significantly increase the lifespan of mice with Ehrlich ascites carcinoma
Presenter: Alexey Bogdanov
Session: ePoster Display
47P - Derazantinib for patients with intrahepatic cholangiocarcinoma harboring FGFR2 fusions/rearrangements: Primary results from the phase II study FIDES-01
Presenter: Michele Droz Dit Busset
Session: ePoster Display
8P - The characterization of tumors associated with the antitumor activity of lenvatinib plus anti-PD-1 antibody combination therapy in a mouse syngeneic model panel
Presenter: Yoichi Ozawa
Session: ePoster Display
9P - Click Activated Protodrugs Against Cancer (CAPAC) platform enhances the safety, pharmacokinetics, and antitumor efficacy of cancer therapies in vivo
Presenter: Sangeetha Srinivasan
Session: ePoster Display
10P - DS-6000a, a novel CDH6-targeting antibody-drug conjugate with a novel DNA topoisomerase I inhibitor DXd, demonstrates potent antitumor activity in preclinical models
Presenter: Hirokazu Suzuki
Session: ePoster Display